Social Media

#Meek Mill 'Expensive Pain' Lands At No. 3 On Billboard 200 Despite Akademiks 'Flop' Claim

#Meek Mill 'Expensive Pain' Lands At No. 3 On Billboard 200 Despite Akademiks 'Flop' Claim

Meek Mill 'Expensive Pain' Lands At No. 3 On Billboard 200 Despite Akademiks 'Flop' Claim

Joseph Okpako/WireImage

Meek Mill can attest to one particular feat — he’s always good for a high Billboard 200 chart debut.

According to HitsDailyDouble, the Dream Chasers rapper’s fifth studio effort debuted at No. 3 on the chart with an estimated 93,000 total album-equivalent units earned. The sales mark earned Meek his fifth consecutive Top 3 debut after 2018’s Championships debuted at No. 1.

In all, each of Meek’s four previous albums has at least been certified gold by the Recording Industry Association of America (RIAA). Since 2012, he’s earned gold or platinum plaques for Dreams and NightmaresDreams Worth More Than MoneyWins & Losses and Championships.

Bolstered by the singles “Flamerz Flow”, “Sharing Locations” and “Blue Notes 2,” Meek’s new album is set to be celebrated in a massive concert in New York later this month featuring Lil Baby and Lil Uzi Vert.

Expensive Pain only trails Taylor Swift’s Fearless (Taylor’s Version) and Drake’s Certified Lover Boy on the new chart, disputing claims Akademiks made about the project in the latest chapter of his war of words with the Philly rapper.

In a video clip shared on Friday (October 8), Akademiks gleefully gloated about Meek’s latest effort selling less than 100,000 units.

“I was praying for times like this for three years,” Akademiks said of Expensive Pain‘s album sales. “Yo Roc Nation, how much y’all pay for this one? My sources says ten bands. Y’all can say whatever, call me a Drake stan, but Drake ain’t never paid for a post.”

If you liked the article, do not forget to share it with your friends. Follow us on Google News too, click on the star and choose us from your favorites.

For forums sites go to Forum.BuradaBiliyorum.Com

If you want to read more Like this articles, you can visit our Social Media category.

Source

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button
Close

Please allow ads on our site

Please consider supporting us by disabling your ad blocker!